Parameters of Blood Lipid Spectrum in Patients with Ischemic Heart Disease During Five Years After the Revascularization Due to Myocardial Infarction

R. Guta, O. Radchenko Danylo Halytsky Lviv National Medical University Introduction. Ischemic heart disease is a leading issue in modern cardiology. Despite the advances in its prophylaxis and treatment, in particular, in the active implementation of surgical techniques, this disease predominates in the structure of morbidity and mortality. At present, there is a sufficient evidence Read More …

The Influence of Pathogenetic Treatment on Peroxidation in Patients with Ischemic Heart Disease and Comorbid Nonalcoholic Steatohepatitis

I. Skrypnyk, G. Maslova, O. Shcherbak HSEE of Ukraine “Ukrainian Medical Stomatological Academy” Introduction. An excessive activation of lipid peroxidation (LP) plays a significant role in pathogenesis of either ischemic heart disease (IHD) or nonalcoholic steatohepatitis (NASH) that in chronic conditions leads to depletion of antioxidant protection (AOP) enzymes with increased risk of cell damage Read More …

Diagnostic and Prognostic Value of Psycho-Autonomic Dysfunction as Factor of Ischemic Heart Failure Progression

O. Katerenchuk, V. Zhdan, I. Katerenchuk The Higher State Educational Institution of Ukraine “Ukrainian Medical Stomatological Academy” Introduction. Coronary arteries disease or, as it still often named, ischemic heart disease is responsible as for premature death in acute conditions (occurrence of acute coronary syndromes) as for premature death caused by progression of chronic heart failure Read More …

The Role of Gene of the Tumor Necrosis factor-alfa G-308A Polymorphism in the Development of Congestive Heart Failure in Patients with Ischemic Heart Disease and Obesity

P. Kravchun, O. Kadykova, N. Ryndina, S. Krapivko Kharkiv National Medical University Introduction. One of the widespread and prognostically unfavourable conditions in cardiovascular diseases is a congestive heart failure (CHF), where an important role is given to the proinflammatory cytokines in the pathogenesis of the disease. Polymorphic variants of the gene of tumor necrosis factor-a Read More …

Risk Factors and Predictors of Ischemic Heart Disease Onset in Females

E. Sklyarov, T. Maksymets Danylo Halytsky Lviv National Medical University Introduction. Ischemic heart disease takes a leading place in morbidity and mortality structure among the Ukrainians and in the world. There are certain peculiarities of the onset, course and prognosis of the ischemic heart disease in women. For example, in women, there is a later Read More …

Myocardial Hibernation in Patients with Arterial Hypertension and Ischemic Heart Disease as a Cause of Heart Failure

O. Barnett, Y. Kyyak, H. Kyyak, V. Kovalyshyn, D. Besh Danylo Halytsky Lviv National Medical University Introduction. Myocardial hibernation refers to “new ischemic syndromes,” which in recent years have increasingly attracted the attention of cardiologists and cardiac surgeons. Hibernation includes a number of adaptive responses: inhibition of metabolic processes to more complex and lengthy pathophysiological Read More …